Differential modulation of N-type calcium channels by µ-opioid receptors in oxytocinergic versus vasopressinergic neurohypophysial terminals

Opioids modulate the electrical activity of magnocellular neurons (MCN) and inhibit neuropeptide release at their terminals in the neurohypophysis. We have previously shown that µ‐opioid receptor (MOR) activation induces a stronger inhibition of oxytocin (OT) than vasopressin (AVP) release from isol...

Full description

Saved in:
Bibliographic Details
Published inJournal of cellular physiology Vol. 225; no. 1; pp. 276 - 288
Main Authors Ortiz-Miranda, Sonia I., Dayanithi, Govindan, Velázquez-Marrero, Cristina, Custer, Edward E., Treistman, Steven N., Lemos, José R.
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.10.2010
Online AccessGet full text

Cover

Loading…
More Information
Summary:Opioids modulate the electrical activity of magnocellular neurons (MCN) and inhibit neuropeptide release at their terminals in the neurohypophysis. We have previously shown that µ‐opioid receptor (MOR) activation induces a stronger inhibition of oxytocin (OT) than vasopressin (AVP) release from isolated MCN terminals. This higher sensitivity of OT release is due, at least in part, to the selective targeting of R‐type calcium channels. We now describe the underlying basis for AVP's weaker inhibition by MOR activation and provide a more complete explanation of the complicated effects on neuropeptide release. We found that N‐type calcium channels in AVP terminals are differentially modulated by MOR; enhanced at lower concentrations but increasingly inhibited at higher concentrations of agonists. On the other hand, N‐type calcium channels in OT terminals were always inhibited. The response pattern in co‐labeled terminals was analogous to that observed in AVP‐containing terminals. Changes in intracellular calcium concentration and neuropeptide release corroborated these results as they showed a similar pattern of enhancement and inhibition in AVP terminals contrasting with solely inhibitory responses in OT terminals to MOR agonists. We established that fast translocation of Ca2+ channels to the plasma membrane was not mediating current increments and thus, changes in channel kinetic properties are most likely involved. Finally, we reveal a distinct Ca‐channel β‐subunit expression between each type of nerve endings that could explain some of the differences in responses to MOR activation. These results help advance our understanding of the complex modulatory mechanisms utilized by MORs in regulating presynaptic neuropeptide release. J. Cell. Physiol. 225: 276–288, 2010. © 2010 Wiley‐Liss, Inc.
Bibliography:UMass Medical School FDSP - No. P60037094900000
National Institute Alcohol Abuse - No. AA08003
istex:CE98F626775354E7FCA9069CF26662CDAEDF4DB2
ark:/67375/WNG-F34J4LMS-Q
ArticleID:JCP22263
National Institute of Health - No. NS24970
National Institute of Drug Abuse - No. DA10487
Steven N. Treistman's present address is Instituto de Neurobiologia, Boulevard del Valle 201, San Juan 00901, Puerto Rico.
Govindan Dayanithi's present address is Department of Cellular Neurophysiology, Academy of Sciences of the Czech Republic, Institute of Experimental Medicine, v.v.i. EU Research Centre of Excellence, Vdenska, 1083, 142 20 Prague 4, Czech Republic.
ISSN:0021-9541
1097-4652
DOI:10.1002/jcp.22263